1. China Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
Hubei Kailong Chemical Group Co., Ltd. Class A

Hubei Kailong Chemical Group Co., Ltd. Class A

SSZSE:002783
7.56
CNY
+0.04
(+0.53%)
0.52EPS
22.50P/E
3.55BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.57
3.53
3.56
2.85
4.02
5.47
5.3
5.19
7.48
8.94
9.7
7.96
7.22
7.46
Basic EPS, GAAP
0.49
0.43
0.39
0.33
0.34
0.24
0.14
0.13
-1.07
0.35
0.45
0.32
0.29
0.32
Free Cash Flow per Basic Share
0.44
0.24
0.6
0.31
-0.03
-0.27
-0.92
-0.48
-0.68
0.07
0.01
0.42
0.76
- -
Dividend per Share
0.23
0.23
0.29
0.15
0.24
0.21
0.31
0.29
0.46
0.3
0.41
0.44
0.23
0.32
Book Value per Share
2.48
2.75
3.81
4.02
4.18
4.53
4.56
4.55
3.41
3.67
4.02
5.07
5.27
5.37
Tangible Book Value per Share
2.05
2.32
3.49
3.39
3.07
3.17
3.62
2.51
1.63
1.96
2.26
3.48
3.4
3.52
Basic Weighted Avg Shares
251
251
250
335
338
341
357
387
369
381
390
463
491
491
Sales/Revenue/Turnover
896
884
891
954
1,359
1,865
1,891
2,011
2,759
3,406
3,779
3,686
3,544
3,665
Operating Margin (%)
18.03
17.87
14.76
14.89
12.16
13.23
13.23
12.81
6.18
10.49
13.16
12.58
12.54
11.88
Depreciation Expense
55
60
65
70
90
116
165
198
299
289
338
350
367
- -
Net Income, GAAP
122
107
98
109
115
82
50
50
-395
133
175
148
142
155
Effective Tax Rate (%)
16.05
20
17.31
18.18
20.72
21.13
26.08
21.18
- -
17.58
18.46
11.79
30.15
27.06
Profit Margin (%)
13.57
12.12
10.96
11.41
8.46
4.38
2.64
2.5
-14.3
3.91
4.64
4.02
4.02
4.24
Working Capital
130
68
672
669
514
839
294
-1,041
-1,357
-1,507
-1,661
-414
28
-16
LT Debt
150
70
50
1
170
882
780
862
957
685
515
818
1,332
1,160
Total Equity
689
768
1,353
1,559
1,658
1,940
2,227
2,637
2,096
2,256
2,503
3,581
3,761
3,816
Return on Invested Capital (%)
14.3
12.15
8.2
7.36
7.49
5.29
3.31
2.5
- -
3.17
5.48
5.84
4.25
4.13
Return on Capital (%)
14.26
11.39
7.7
6.2
5.64
2.22
0.67
1.69
- -
4.7
4.34
2.6
1.57
1.71
Return on Common Equity (%)
21.07
16.37
9.96
8.32
8.4
5.63
3.1
2.93
-26.14
9.75
11.67
7.22
5.52
5.92

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
963
1,410
1,267
LT Borrowings
1,314
901
1,143
LT Finance Leases
18
12
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
499
499
499
Market Capitalization
4,779
4,594
3,550

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,272
2,967
3,148
Cash, Cash Equivalents & STI
1,179
1,051
959
Accounts Receivable, Net
1,004
998
1,175
Inventories
327
342
397
Total Current Liabilities
3,244
3,293
3,164
Payables & Accruals
- -
- -
- -
ST Debt
963
1,410
1,267
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.79%
9.23%
5.05%
Free Cash Flow
504.96%
811.61%
93.68%
Net Income, GAAP
-105.55%
-201.13%
-3.87%
Sales/Revenue/Turnover
15.99%
13.06%
-3.85%
Total Cash Common Dividend
11.83%
8.49%
-43.74%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
675
964
931
1,117
3,686
2025
764
977
- -
975
3,544
2026
715
998
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.08
0.1
0.07
0.32
2025
0.07
0.14
- -
0.01
0.29
2026
0.02
0.14
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.08
0.18
0.02
0.21
0.44
2025
0.04
0.14
- -
- -
0.23
2026
0.05
0.12
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Shi Hua Luo
Full Time Employees
4,442
Sector
Process industries
Industry
Chemicals: major diversified
Address
20th Quankou Road Jingmen HB China 448001
IPO Date
Dec 8, 2015
Website
hbklgroup.cn
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
AARTI Industries Ltd (NSE:AARTIIND)
Aether Industries Ltd. (NSE:AETHER)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Hubei Kailong Chemical Group Co., Ltd. engages in the production and sale of civil explosives, chemical products, mining materials, engineering blasting services, and modern logistics primarily within China. Its core products comprise civil explosives including emulsion explosives, expanded ammonium nitrate explosives, modified ANFO, and seismic charges, with licensed production capacities exceeding 280,000 tons annually; chemical products such as ammonium nitrate, compound fertilizers, and synthetic ammonia with production capacities up to 800,000 tons per year for fertilizers and 200,000 tons for ammonia; mining products including construction aggregates, calcium oxide, and nano calcium carbonate; blasting services operated through 15 qualified blasting companies; and logistics services involving hazardous materials transport with a fleet of 336 vehicles. Founded in 1967 and headquartered in Jingmen, Hubei Province, the company has developed a diversified industrial chain with subsidiaries and branches across multiple Chinese provinces. Recently, Hubei Kailong Chemical Group expanded strategically by acquiring a 51.1% stake in Maxam Chemical Co., Ltd. from Maxamcorp International SL for approximately CNY 90 million, enhancing its explosives and chemical product portfolio. The company reported a 20.64% year-on-year increase in net profit attributable to shareholders in the first three quarters of 2025 despite a marginal revenue decline, reflecting improved profitability and operational efficiency. It continuously invests in R&D through its research institutes and innovation centers, focusing on green development and intelligent production technologies, including ongoing projects like synthetic ammonia energy-saving and environmental protection upgrades. This diversified enterprise integrates manufacturing, scientific research, mining, and logistics, targeting industrial, mining, and agricultural markets across China. Its comprehensive product and service scope and recent acquisition reinforce its position as a leading provider in China's civil explosives and chemical sectors. The company was listed on the Shenzhen Stock Exchange in 2015, and it maintains significant R&D capacity with hundreds of patents and several national-level innovation platforms supporting its technology-driven growth strategy.